{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:41:25Z","timestamp":1760100085987},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1007\/bf02982116","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T13:12:52Z","timestamp":1226322772000},"page":"514-518","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pure Red Cell Aplasia Developing into Myeloproliferation with Myelodysplasia and Subsequent Leukemia after Cyclosporin A Therapy"],"prefix":"10.1007","volume":"75","author":[{"given":"Takahiro","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Shirasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,6,1]]},"reference":[{"key":"BF02982116_CR1","first-page":"275","volume":"28","author":"EN. Dessypris","year":"1991","unstructured":"Dessypris EN.The biology of pure red cell aplasia.Semin Hematol. 1991;28:275\u2013284.","journal-title":"Semin Hematol."},{"key":"BF02982116_CR2","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1365-2141.2000.02429.x","volume":"111","author":"P Fisch","year":"2000","unstructured":"Fisch P, Handgretinger R, Schaefer H-E. Pure red cell aplasia.Br J Haematol. 2000;111:1010\u20131022.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes.Br J Haematol. 1982;51: 189\u2013199.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/jcp.41.11.1168","volume":"41","author":"A Craig","year":"1988","unstructured":"Craig A, Geary CG, Love EM, Liu-Yin J. Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome.J Clin Pathol. 1988;41:1168\u20131170.","journal-title":"J Clin Pathol."},{"key":"BF02982116_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/jcp.42.8.890","volume":"42","author":"MK. Cook","year":"1988","unstructured":"Cook MK. Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndrome.J Clin Pathol. 1988;42:890\u2013891.","journal-title":"J Clin Pathol."},{"key":"BF02982116_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2257.1989.tb00176.x","volume":"11","author":"PHB Bolton-Maggs","year":"1989","unstructured":"Bolton-Maggs PHB, Galloway MJ, Rhodes EG. Pure red cell aplasia heralding chronic myelomonocytic leukaemia.Clin Lab Haematol. 1989;11:61\u201365.","journal-title":"Clin Lab Haematol."},{"key":"BF02982116_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2257.1989.tb00243.x","volume":"11","author":"A Lopez-Guillermo","year":"1989","unstructured":"Lopez-Guillermo A, Cervantes F, Sacanella E, Florensa L, Rozman C. Pure red cell aplasia associated with chronic myelomonocytic leukaemia.Clin Lab Haematol. 1989;11:410\u2013411.","journal-title":"Clin Lab Haematol."},{"key":"BF02982116_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jcp.44.5.431","volume":"44","author":"PJ Williamson","year":"1991","unstructured":"Williamson PJ, Oscier DG, Bell AJ, Hamblin TJ. Red cell aplasia in myelodysplastic syndrome.J Clin Pathol. 1991;44:431\u2013432.","journal-title":"J Clin Pathol."},{"key":"BF02982116_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<319::AID-AJH12>3.0.CO;2-2","volume":"58","author":"J Garcia-Suarez","year":"1998","unstructured":"Garcia-Suarez J, Pascual T, Munoz MA, Herrero B, Pardo A. Myelodysplastic syndrome with erythroid hypoplasia\/aplasia: a case report and review of the literature.Am J Hematol. 1998;58: 319\u2013325.","journal-title":"Am J Hematol."},{"key":"BF02982116_CR10","first-page":"34","volume":"40","author":"A Yokohama","year":"1999","unstructured":"Yokohama A, Murata N, Shimano S, et al. Myelodysplastic syndrome accompanied by i(17) (q10) anomaly following pure red cell aplasia and transient myeloproliferative stage.Jpn J Clin Hematol.1999;40:34\u201339.","journal-title":"Jpn J Clin Hematol."},{"key":"BF02982116_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s002770050183","volume":"72","author":"S Hashino","year":"1996","unstructured":"Hashino S, Imamura M, Tanaka J, et al. Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7.Ann Hematol. 1996;72:337\u2013339.","journal-title":"Ann Hematol."},{"key":"BF02982116_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2141.1998.00551.x","volume":"100","author":"A Jonasova","year":"1998","unstructured":"Jonasova A, Neuwirtova R, Cermak J, et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anemias without hypoplastic bone marrow.Br J Haematol. 1998;100:304\u2013309.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2141.1988.tb04194.x","volume":"68","author":"A Tichelli","year":"1988","unstructured":"Tichelli A, Gratwohl A, Wuersch A, Nissen C, Speck B. Antilymphocyte globulin for myelodysplastic syndrome?Br J Haematol.1988;68:139\u2013140.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR14","first-page":"322","volume":"28","author":"PA Miescher","year":"1991","unstructured":"Miescher PA, Favre H, Beris P. Autoimmune myelodysplasias.Semin Hematol. 1991;28:322\u2013330.","journal-title":"Semin Hematol."},{"key":"BF02982116_CR15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood.V79.6.1385.1385","volume":"79","author":"NS. Young","year":"1992","unstructured":"Young NS. The problem of clonality in aplastic anemia: Dr Dameshek\u2019s riddle, restarted.Blood. 1992;79:1385\u20131392.","journal-title":"Blood"},{"key":"BF02982116_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","volume":"91","author":"H Enright","year":"1995","unstructured":"Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelo-dysplastic syndromes: response to immunosuppressive therapy.Br J Haematol. 1995;91:403\u2013408.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y","volume":"79","author":"DH Biesma","year":"1997","unstructured":"Biesma DH, van den Tweel JG, Verdonck LF. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.Cancer. 1997; 79:1548\u20131551.","journal-title":"Cancer"},{"key":"BF02982116_CR18","first-page":"1093","volume":"40","author":"M Takanashi","year":"1999","unstructured":"Takanashi M, Kadono Y, Tabata Y, Hibi S. Successful immunosup-pressive therapy for a patient with hypoplastic myelodysplastic syndrome.Jpn J Clin Hematol. 1999;40:1093\u20131099.","journal-title":"Jpn J Clin Hematol."},{"key":"BF02982116_CR19","first-page":"133","volume":"85","author":"L Catalano","year":"2000","unstructured":"Catalano L, Selleri C, Califano C, et al. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.Haematologica. 2000;85:133\u2013138.","journal-title":"Haematologica"},{"key":"BF02982116_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1365-2141.1999.1249d.x","volume":"104","author":"Y Nemoto","year":"1999","unstructured":"Nemoto Y, Tsutani H, Imamura S, et al. Successful treatment of acquired myelofibrosis with pure red cell aplasia by cyclosporine.Br J Haematol. 1999;104:422\u2013424.","journal-title":"Br J Haematol."},{"key":"BF02982116_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0268-960X(91)90041-A","volume":"5","author":"IM. Weinstein","year":"1991","unstructured":"Weinstein IM. Idiopathic myelofibrosis: historical review, diagnosis and management.Blood Rev. 1991;5:98\u2013104.","journal-title":"Blood Rev."},{"key":"BF02982116_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s002770050286","volume":"74","author":"M Garcia-Isidoro","year":"1997","unstructured":"Garcia-Isidoro M, Tabernero MD, Najera ML, et al. Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders.Ann Hematol. 1997;74: 209\u2013214.","journal-title":"Ann Hematol."},{"key":"BF02982116_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0165-4608(94)00228-4","volume":"82","author":"F Fagioli","year":"1995","unstructured":"Fagioli F, Cuneo A, Bardi A, et al. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome: a multipa-rameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.Cancer Genet Cytogenet. 1995;82:116\u2013122.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF02982116_CR24","first-page":"109","volume":"9","author":"G Fugazza","year":"1995","unstructured":"Fugazza G, Bruzzone R, Dejana AM, et al. Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization.Leukemia. 1995;9:109\u2013114.","journal-title":"Leukemia"},{"key":"BF02982116_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0165-4608(96)00115-X","volume":"92","author":"A Elis","year":"1996","unstructured":"Elis A, Amiel A, Manor Y,Tangi I, Fejgin M, Lishner M.The detec- tion of trisomies 8 and 9 in patients with essential thrombocytosis by fluorescence in situ hybridization.Cancer Genet Cytogenet. 1996;92:14\u201317.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF02982116_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1040-8428(01)00101-9","volume":"40","author":"P Mhawech","year":"2001","unstructured":"Mhawech P, Saleem A. Myelodysplastic syndrome: review of the cytogenetic and molecular data.Crit Rev Oncol Hematol. 2001;40: 229\u2013238.","journal-title":"Crit Rev Oncol Hematol."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T01:35:52Z","timestamp":1589074552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["BF02982116"],"URL":"https:\/\/doi.org\/10.1007\/bf02982116","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}